Patients & CaregiversHealthcare ProfessionalsWorldwide
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
THE MERCK MANUAL MEDICAL LIBRARY: The Merck Manual of Diagnosis and Therapy
Tips for better results
ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Section

Subject

Topics

Q Fever

Update Me

Q fever is an acute or chronic disease caused by the rickettsial-like bacillus Coxiella burnetii. Acute disease causes sudden onset of fever, headache, malaise, and interstitial pneumonitis. Chronic disease manifestations reflect the organ system affected. Diagnosis is confirmed by several serologic techniques, isolation of the organism, or PCR. Treatment is with doxycycline or chloramphenicol.

Coxiella burnetii is a small, intracellular, pleomorphic bacillus that is no longer classified as Rickettsia. Molecular studies have reclassified it as Proteobacteria in the same group as Legionella sp.

Q fever can be acute or chronic. Acute disease causes a febrile illness that often affects the respiratory system, although sometimes the liver is involved. Chronic Q fever usually manifests as endocarditis or hepatitis; osteomyelitis may occur.

Worldwide in its distribution, Q fever is maintained as an inapparent infection in domestic or farm animals. Sheep, cattle, and goats are the principal reservoirs for human infection. C. burnetii persists in stool, urine, milk, and tissues (especially the placenta), so that fomites and infective aerosols form easily. C. burnetii is also maintained in nature through an animal-tick cycle.

Etiology

Cases occur among workers whose occupations bring them in close contact with farm animals or their products. Transmission is usually by inhalation of infected aerosols, but the disease can also be contracted by ingesting infective raw milk. C. burnetii is very virulent, resists inactivation, and remains viable in dust and stool for months; even a single organism can cause infection. Very rarely, the disease is transmitted from person to person.

Symptoms and Signs

The incubation period averages 18 to 21 days (range 9 to 28 days). Some infections are minimally symptomatic; however, most patients have influenza-like symptoms. Onset is abrupt, with fever, severe headache, chills, severe malaise, myalgia, anorexia, and sweats. Fever may rise to 40° C and persist 1 to > 3 wk. Respiratory symptoms (a dry nonproductive cough, pleuritic chest pain) appear 4 to 5 days after onset of illness. These symptoms may be particularly severe in elderly or debilitated patients. During examination, lung crackles are commonly noted, and findings suggesting consolidation may be present. Unlike rickettsial diseases, acute Q fever does not cause a rash.

Acute hepatic involvement, occurring in some patients, resembles viral hepatitis, with fever, malaise, hepatomegaly with right upper abdominal pain, and possibly jaundice. Headache and respiratory signs are frequently absent. Chronic Q fever hepatitis may manifest as FUO. Liver biopsy may show granulomas, which should be differentiated from other causes of liver granulomas (eg, TB, sarcoidosis, histoplasmosis, brucellosis, tularemia, syphilis).

Endocarditis resembles viridans group subacute bacterial endocarditis (see Endocarditis: Infective Endocarditis); the aortic valve is most commonly affected, but vegetations may occur on any valve. Marked finger clubbing, arterial emboli, hepatomegaly, splenomegaly, and a purpuric rash may occur.

The mortality rate is only 1% of untreated patients but is higher in those with endocarditis. Some patients with neurologic involvement have residual impairment.

Diagnosis

Symptoms do not readily suggest the diagnosis. Early on, Q fever resembles many infections (eg, influenza, other viral infections, salmonellosis, malaria, hepatitis, brucellosis). Later, it resembles many forms of bacterial, viral, and mycoplasmal pneumonias. Contact with animals or animal products is an important clue.

Immunofluorescence assay (IFA) of infected tissue is the diagnostic method of choice; alternatively, enzyme-linked immunosorbent assay (ELISA) may be done. Acute and convalescent serum specimens (typically complement fixation) may be used. PCR can identify the organism in biopsy specimens. C. burnetii may be isolated from clinical specimens, but only by special research laboratories; routine blood and sputum cultures are negative.

Patients with respiratory symptoms or signs require chest x-ray; findings may include atelectasis, pleural-based opacities, pleural effusion, and lobar consolidation. The gross appearance of the lungs may resemble bacterial pneumonia but, histologically, more closely resembles psittacosis and some viral pneumonias.

In acute Q fever, CBC may be normal, but about 30% of patients have an elevated WBC count. Alkaline phosphatase, AST, and ALT levels are mildly elevated to 2 to 3 times the normal level in typical cases. If obtained, liver biopsy specimens often show diffuse granulomatous changes.

Treatment

Primary treatment is doxycycline Some Trade Names
PERIOSTAT
VIBRAMYCIN
Click for Drug Monograph
200 mg po once followed by 100 mg po bid until the patient improves and has been afebrile for about 5 days but continued for at least 7 days. Chloramphenicol Some Trade Names
CHLOROMYCETIN
Click for Drug Monograph
500 mg po or IV qid for 7 days is 2nd-line treatment. Fluoroquinolones and macrolides are also effective.

For endocarditis, treatment needs to be prolonged (months to years to lifelong). Clinical signs and ESR, blood count and antibody titers should be monitored to determine when to stop treatment. A tetracycline Some Trade Names
ACHROMYCIN V
TETRACYN
TETREX
Click for Drug Monograph
plus rifampin Some Trade Names
RIFADIN
RIMACTANE
Click for Drug Monograph
or ciprofloxacin Some Trade Names
CILOXAN
CIPRO
Click for Drug Monograph
is usually preferred. Some experts use hydroxychloroquine Some Trade Names
PLAQUENIL
Click for Drug Monograph
as an additional drug. When antibiotic treatment is only partially effective, damaged valves must be replaced surgically, although some cures have occurred without surgery. Clear-cut regimens for chronic hepatitis have not been determined.

Prevention

Vaccines are effective and should be used to protect slaughterhouse and dairy workers, rendering-plant workers, herders, woolsorters, farmers, and other people at risk. These vaccines are not available commercially but may be obtained from special laboratories (eg, the US Army Medical Research Institute of Infectious Diseases in Fort Detrick, Maryland).

Last full review/revision November 2007 by William A. Petri, Jr., MD, PhD

Content last modified November 2007

Back to Top

Previous: Murine (Endemic) Typhus

Next: Rickettsialpox

Audio
Figures
Photographs
Tables
Videos
Contact UsSite MapPrivacy PolicyTerms of UseCopyright 1995-2007 Merck & Co., Inc.